Prescott General Partners’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,265
| Closed | -$71.3K | – | 9 |
|
|
2023
Q4 | $71.3K | Hold |
5,265
| – | – | ﹤0.01% | 9 |
|
|
2023
Q3 | $126K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2023
Q2 | $165K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2023
Q1 | $123K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2022
Q4 | $102K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2022
Q3 | $104K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2022
Q2 | $107K | Hold |
5,265
| – | – | 0.01% | 12 |
|
|
2022
Q1 | $158K | Hold |
5,265
| – | – | 0.01% | 12 |
|
|
2021
Q4 | $202K | Hold |
5,265
| – | – | 0.01% | 15 |
|
|
2021
Q3 | $174K | Hold |
5,265
| – | – | 0.01% | 14 |
|
|
2021
Q2 | $287K | Hold |
5,265
| – | – | 0.01% | 9 |
|
|
2021
Q1 | $300K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2020
Q4 | $281K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2020
Q3 | $150K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2020
Q2 | $175K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2020
Q1 | $172K | Hold |
5,265
| – | – | 0.01% | 9 |
|
|
2019
Q4 | $337K | Hold |
5,265
| – | – | 0.02% | 10 |
|
|
2019
Q3 | $363K | Hold |
5,265
| – | – | 0.01% | 10 |
|
|
2019
Q2 | $680K | Hold |
5,265
| – | – | 0.03% | 10 |
|
|
2019
Q1 | $750K | Hold |
5,265
| – | – | 0.03% | 10 |
|
|
2018
Q4 | $554K | Buy |
+5,265
| New | +$554K | 0.02% | 11 |
|